Boditech Med Inc.
Financials
Valuation Metrics
Boditech Med Inc.'s Market Cap is ₩1847B. At end of 2025 it was ₩2874B. Ranked #842 of 2,405 in KR market (top 35%), #383 of 1,627 on KOSDAQ (top 24%), #26 of 94 in Health Care Equipment & Services (top 28%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 184.68B KRW | KR#842/2,405 Sec#26/94 |
| Revenue | 174.78B KRW | KR#1,104/2,405 Sec#15/94 |
| Net Income | 26.31B KRW | KR#601/2,405 Sec#13/94 |
| Total Assets | 303.62B KRW | KR#1,030/2,405 Sec#22/94 |
| Net Assets | 261.45B KRW | KR#793/2,405 Sec#18/94 |
| Employees | 532 | KR#466/2,405 Sec#7/94 |
| Value | ||
| P/E | 7.02x | KR#630/2,405 Sec#17/94 |
| P/B | 0.71x | KR#1,206/2,405 Sec#25/94 |
| PEG | 0.01x | KR#113/2,405 Sec#4/94 |
| P/S | 1.06x | KR#1,474/2,405 Sec#33/94 |
| EV/EBITDA | 6.69x | KR#405/2,405 Sec#12/94 |
| FCF Yield | -5.92% | KR—/2,405 Sec—/94 |
| Profitability | ||
| ROE | 10.06% | KR#610/2,405 Sec#26/94 |
| ROA | 8.67% | KR#371/2,405 Sec#21/94 |
| Op. Margin | 15.28% | KR#292/2,405 Sec#22/94 |
| Revenue Growth | 16.99% | KR#621/2,405 Sec#33/94 |
| Earnings Growth | 701.19% | KR#87/2,405 Sec#4/94 |
| Financial Health | ||
| Debt Ratio | 16.13% | KR#276/2,405 Sec#17/94 |
| Total Debt | 32.43B KRW | KR#1,181/2,405 Sec#28/94 |
| FCF | -10.93B KRW | KR#1,727/2,405 Sec#64/94 |
| Cash | 38.40B KRW | KR#875/2,405 Sec#21/94 |
| Current Ratio | 5.46x | KR#250/2,405 Sec#21/94 |
| Net Debt/EBITDA | -0.22x | KR#560/2,405 Sec#22/94 |
| Dividend | ||
| Div. Yield | 1.76% | KR#977/2,405 Sec#26/94 |
| Div. Growth | 0.00% | KR—/2,405 Sec—/94 |
| Performance | ||
| 1Y Return | -37.88% | KR#1,655/2,405 Sec#56/94 |
| 1M Return | -13.54% | KR#1,454/2,405 Sec#57/94 |
| From 52W High | -40.84% | KR#777/2,405 Sec#29/94 |
| 1Y MDD | -39.87% | KR#561/2,405 Sec#17/94 |
| Trading | ||
| Volume | 11,966 shares | KR#1,761/2,405 Sec#70/94 |
| Trading Value | 100.9M KRW | KR#1,434/2,405 Sec#56/94 |
| Foreign Own. | 3.52% | KR#1,145/2,405 Sec#37/94 |
| Per Share | ||
| EPS | 1,201 KRW | KR#649/2,405 Sec#13/94 |
| BPS | 11,934 KRW | KR#861/2,405 Sec#17/94 |
Company Info
Boditech Med, established in 1998 as an in-vitro diagnostics specialist, operates production corporations in the US and China, expanding its diagnostics market. Leveraging lateral flow immunofluorescence technology, the company possesses over 100 types of disease diagnostic product lines and has diversified sales channels by establishing sales networks in over 130 countries worldwide. It has developed next-generation and automated immunoassay platforms, laying the groundwork for entry into advanced markets and large hospitals, and is aspiring to become a global diagnostics company through the development of high-value-added diagnostic cartridges. Its headquarters are in Chuncheon-si, Gangwon-do.